Sanofi (SAN)

Index:

82.49

By Michele Maatouk

Date: Monday 02 Jun 2025

(Sharecast News) - Sanofi said on Monday that it has agreed to buy US biopharmaceutical firm Blueprint Medicines for $9.1bn.

Pharma stocks slide as Trump threatens price cut...	12-May-2025	ShareCast
Sanofi to sell 50% stake in Opella to CD&R	21-Oct-2024	ShareCast
Sanofi in talks to sell consumer healthcare stak...	11-Oct-2024	ShareCast
Novavax signs $1.2bn Covid-19 licensing deal wit...	10-May-2024	ShareCast
Sanofi shares tank on consumer spin-off plans, Q...	27-Oct-2023	ShareCast

Sanofi-Aventis buys Genzyme with $20bn sweetened...	17-Feb-2011	Telegraph
Sanofi agrees long-awaited takeover of Genzyme	17-Feb-2011	The Independent
Genzyme: Sanofi-Aventis to buy U.S. biotech comp...	17-Feb-2011	BayArea.com
Sanofi Agrees to Buy Genzyme for $20.1 Billion	17-Feb-2011	New York Times
Genzyme Again Rejects Sanofi’s Bid	08-Oct-2010	New York Times

Patent Woes Threaten Drug Firms	07-Mar-2011	New York Times
Sanofi Bid for Genzyme Turns Hostile, and No Swe...	05-Oct-2010	Intl Herald Tribune
Sanofi and Merck Announce $4 Billion Merial Sale	31-Jul-2009	Intl Herald Tribune
Sanofi Drug for Heart Rhythm Disorder Is Approved	04-Jul-2009	Intl Herald Tribune
Big drug makers may seek to fill holes in roster	25-Feb-2009	Intl Herald Tribune

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.